Life Science

ValiRX establishes first US office in Cambridge

Cambridge, MA – United Kingdom-based ValiRx Plc recently announced the opening of its new North American office in Cambridge, Massachusetts. Located in Kendall Square, the office is the firm’s first North American location. ValiRx is a life science company with a focus on cancer therapeutics and epigenetic cancer diagnostics for personalized medicine. It listed on the London Stock Market in 2006.

 

“We welcome UK-based ValiRx as the latest international company to put down roots in the Massachusetts life sciences community,” said Governor Charlie Baker. “ValiRx will join a strong concentration of companies in Massachusetts that are developing the next generation of cancer therapies.”

 

Massachusetts is a world renowned hub for biotech and life-sciences, with a large number and variety of biotech and biopharma companies in the region making our decision to open an office there both easy and very compelling. Our proximity to so many potential customers is most definitely an advantage,” said Dr. Satu Vainikka, CEO of Valirx.

 

We are also pleased to announce that we have strengthened our US advisory team following the appointment of various advisors in the US to support us in our work. Our US operation is being formed to encourage and facilitate greater interaction with US-based academic, clinical and business leaders in our specialist areas of oncological development and we chose Kendall Square in Cambridge MA so as to be part of Kendall Square’s strong biotech community,” said Dr. Vainikka.

 

I would like to extend our congratulations to ValiRx on the establishment of their first U.S. office in Cambridge,” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. “The MLSC has been in dialogue with ValiRx for the last two years on their expansion plansThis new office will enable ValiRx to make important contributions to cancer therapeutics and diagnostics, and to the Massachusetts life sciences community, in the world’s leading ecosystem for life sciences innovation and growth.”

 

 

“The economic ties between the UK and Massachusetts are very strong; nowhere is that more evident than in our world-leading, highly networked and transformational Life Sciences industries. I am thrilled that ValiRx has selected Cambridge, MA as the location for its first North American office. Companies like ValiRx prove that the UK/US partnership continues to benefit both our nations by building on our shared great science, talent and vision to create jobs and prosperity,” said Susie Kitchens, HM Consul General to Boston.

 

“We are thrilled to welcome ValiRx to Massachusetts and we congratulate them on establishing their first U.S. operations in Cambridge,” said Robert K. Coughlin, President & CEO of MassBio. “We know ValiRx will thrive here as they connect with and contribute to Massachusetts’ robust oncology research and development community.”